QUANT-EQUIPOISE 300 BY BELIGAS PHARMACEUTICALS

Injectable Oily Solution

DRUG COMPOSITION

1 mL of solution contains:
- active substance: boldenone undecylenate 300 mg;
- auxiliary substances:

DRUG DESCRIPTION

Transparent oily solution, from yellow to light yellow color, with characteristic smell.

PHARMACEUTICAL FORM

Injectable oily solution.

PHARMACEUTICAL GROUP AND ATC CODE

Androgen; Anabolic Steroid; Androgen Ester.

PHARMACOLOGICAL PROPERTIES

PROFILE

Half life: 14 Days
Routes of administration: intramuscular injection
Dosage forms: (Men): 400-1000 mg/week; (Women): -
Acne: rarely
Water retention: low
High blood pressure: no
Hepatotoxicity: low
Aromatase: low
Decreased HPTA function (own testosterone production): moderate
Anabolic activity: 100%
Androgenic activity: 50%
Detection time:

THERAPEUTICAL INDICATIONS

DOSES AND METHOD OF ADMINISTRATION

SIDE EFFECTS

CONTRAINDICATIONS

OVERDOSE

INTERACTIONS WITH OTHER DRUGS

PRESENTATION, PACKAGING

Injectable oily solution 300 mg / 1 mL in 10 mL Vial vials.

STORAGE

Store in a dry place and away from light at 15-25 ° C. Keep out of the reach and sight of children.

LEGAL STATUS

It is issued with prescription.

DATE OF LAST TEXT CHECKS

March 2020

NAME AND ADDRESS OF THE MANUFACTURER

Beligas Pharmaceuticals
Belgium